Cover Image

Outcomes of patients with EGFR-mutant advanced NSCLC in a developing country in Southeast Asia

Background: Although first-and second-generation EGFR TKIs are considered first-line treatment in EGFRm+ NSCLC, most patients develop resistance and progress, commonly, EGFR T790M mutation. The third-generation EGFR-TKI has demonstrated efficacy in patients with progressive disease harboring the T79...

Full description

Saved in:
Bibliographic Details
Main Authors: How, Soon Hin, Liam, Chong Kin, Abidin, Muhammad Adil Zainal, Hasbullah, Harissa H., Tho, Lye Mun, Ho, Gwo Fuang, Nor, Ibtisam Muhamad, Pang, Yong Kek, Ho, Kean Fatt, Thiagarajan, Muthukkumaran, Ariffin, Roziana, Samsudin, Azlina, Omar, Azza, Tan, Sin Nee, Ong, Choo Khoon, Soon, Sing Yang, Poh, Mau Ern
Format: Article
Published: Dove Medical Press LTD 2022
Subjects:
R Medicine
Online Access:http://eprints.um.edu.my/42092/
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first

Similar Items